Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiyo Pacific Partners is an asset management and private equity firm specializing in friendly activist investing, primarily targeting small to mid-cap public and private companies in Asia, especially Japan. The firm is known for its hands-on engagement with portfolio companies to unlock long-term value through strategic consulting, investment management, and operational improvements. As of 2022, it manages over $3.7 billion in Japan and India-focused funds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiyo Pacific Partners.